COVID-19 and the Cold Chain: Lessons from the front lines of the vaccine rollout

Article Summary: Ensuring the safe handling, delivery and administration of more than a half-billion COVID-19 vaccines in the United States in less than two years was an unprecedented logistical feat. But distributing the two approved mRNA vaccines from Pfizer-BioNTech and Moderna has been a particular challenge, given the vaccines’ extreme temperature control requirements, according to […]

WTO members applaud the Quad document as a foundation for text-based pandemic IP response negotiations

Excerpt WTO members agreed on May 10 at a General Council meeting that the outcome document from the informal process with the Quad (European Union, India, South Africa, and the United States) opens the door to text-based talks on an intellectual property response to COVID-19. Members praised the proposal as a constructive step forward and […]

Moderna files for authorization of its COVID-19 Vaccine in young children six months to under six years of age

Excerpt Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that it has submitted an emergency use authorization (EUA) request to the US Food and Drug Administration for its COVID-19 vaccine (mRNA-1273) in children aged 6 months to under 2 years and 2 years to under 6 years, as well […]

IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program

Excerpt The nonprofit scientific research organization IAVI and Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant screenings are soon to start for a Phase I clinical trial of an mRNA HIV vaccine antigen (mRNA-1644) at the Center for Family Health Research (CFHR) in Kigali, Rwanda, […]

DFC to finance up to US$ 1 billion for Gavi COVID-19 vaccine and ancillary supply purchase and delivery

Excerpt The new COVAX Rapid Financing Facility, which was announced during the White House COVID-19 Summit, would give the COVAX AMC with the cash it needs to respond to unforeseen risks. Gavi will be able to monetize COVAX AMC pledges as soon as they are made by sovereign and private sector donors, allowing for faster […]

SINOVAC Omicron-specific vaccine approved for clinical trial in Hong Kong

Excerpt: Sinovac Biotech Ltd. (“SINOVAC”) has received approval for a clinical trial of their inactivated COVID-19 vaccine (Omicron strain) in Hong Kong, China. Article Summary Sinovac Biotech Ltd. (“SINOVAC”) has received approval for a clinical trial of their inactivated COVID-19 vaccine (Omicron strain) in Hong Kong, China. During the year 2021, SINOVAC continued to work […]

Catalent Expands Biologics Capabilities in the UK and Across Europe by Acquiring Facility in Oxfordshire

Excerpt Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimise the development, launch, and supply of better patient treatments across multiple modalities, today announced the acquisition of a biologics development and manufacturing facility currently under construction near Oxford, United Kingdom, from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC […]

Austria’s newly developed COVID vaccination could protect against omicron and other variants

Excerpt: Preclinical data for a SARS-CoV-2 vaccine developed at MedUni Vienna shows that it is effective against all SARS-CoV-2 variants known to date, including omicron, even in patients who have not yet developed immunity as a result of vaccination (non-responders) Article Summary The antigen-based vaccine developed at MedUni Vienna, led by Rudolf Valenta of the […]

Pfizer and BioNTech have released data showing a strong immune response in children aged 5 to 11 years old after receiving a booster dose of their COVID-19 vaccine

Excerpt Following a booster (third) dose of the Pfizer-BioNTech COVID-19 Vaccine, data from a subanalysis of 30 sera from a Phase 2/3 clinical study of children aged 5 to 11 years old reveal a 36-fold rise in SARS-CoV-2 Omicron neutralising titers. A booster (third) dose of the Pfizer-BioNTech COVID-19 Vaccine enhanced neutralising antibodies against the […]

Singapore and Asia’s leading BioPharma Map the Future and Catalyze Recovery for the Biomanufacturing Industry

Singapore, 31st March 2022 – The 9th Annual Biologics Manufacturing Asia 2022 & the 6th Annual BioLogistics World Asia 2022 conferences kicks off with Industry views on post pandemic biomanufacturing and a focus on the future of Asia’s Bioprocessing sector. The annual event gathered biologics and vaccine experts from all over the world at Suntec […]

Biovac and Development Partners Collaborate to Help South Africa Expand Its Vaccine Manufacturing Capacity and Advance Africa’s Long-Term Health Security

Excerpt Consortium of nine development partners to support Biovac’s expansion of its existing vaccine manufacturing plant capacity, and enable the production of Pfizer-BioNTech’s COVID-19 vaccine and other vaccines. Biovac plans to raise about $150 million (ZAR2.3 billion) to expand indigenous vaccine manufacturing capacity across Africa. Partners include AfDB, CDC Group, DEG, DFC, EIB, IFC, Proparco, […]

Nipah Survivors Study to Advance New Vaccines Against Highly Fatal Threat

Excerpt CEPI will expand its collaboration with icddr,b in Bangladesh, offering nearly $1 million in financing to help researchers better understand the Nipah virus. The Nipah virus is still one of the most lethal illnesses known to humans, but no vaccinations are currently approved for use. The research will also aid in the development of […]